Hakam Abbass
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 and COVID-19 Research 8
-
- Atrial Fibrillation Management and Outcomes 6
- Cardiac Arrhythmias and Treatments 2
- Co-authors
- Ross Jacob Hunter (8 shared papers)Mark J. Earley (4 shared papers)Pier David Lambiase (5 shared papers)Shohreh Honarbakhsh (10 shared papers)Simon Sporton (3 shared papers)Anthony Chow (7 shared papers)Gurpreet Singh Dhillon (4 shared papers)Sophie Welch (2 shared papers)
- Journals
- The Lancet (6 papers)JAMA (5 papers)Journal of Cardiovascular Electrophysiology (4 papers)Wellcome Open Research (2 papers)Science (2 papers)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
Hakam Abbass
26 papers receiving 2.7k citations
Hakam Abbass's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.6k
- Neurology 416
- Internal Medicine 82
- Modeling and Simulation 79
- Critical Care and Intensive Care Medicine 76
Countries citing papers authored by Hakam Abbass
This map shows the geographic impact of Hakam Abbass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakam Abbass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakam Abbass more than expected).
Fields of papers citing papers by Hakam Abbass
This network shows the impact of papers produced by Hakam Abbass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakam Abbass. The network helps show where Hakam Abbass may publish in the future.
Co-authors
The 25 scholars most cited alongside Hakam Abbass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 2 | Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 Hit paper breakdown → | 2021 | 309 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Hit paper breakdown → | 2019 | 264 |
| 5 | Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure Hit paper breakdown → | 2022 | 255 |
| 6 | 2021 | 249 | |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 8 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 9 | 2022 | 104 | |
| 10 | 2022 | 99 | |
| 11 | 2023 | 83 | |
| 12 | 2021 | 70 | |
| 13 | 2021 | 48 | |
| 14 | 2023 | 45 | |
| 15 | 2023 | 34 | |
| 16 | 2022 | 27 | |
| 17 | 2020 | 18 | |
| 18 | 2020 | 17 | |
| 19 | 2024 | 12 | |
| 20 | 2022 | 9 |
About Hakam Abbass
Hakam Abbass is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Modeling and Simulation, Pulmonary and Respiratory Medicine and Neurology, having authored 29 papers that have together received 2.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Atrial Fibrillation Management and Outcomes (6 papers), vaccines and immunoinformatics approaches (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Infection Control and Ventilation (1 paper), COVID-19 epidemiological studies (1 paper) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Infectious Diseases (1.6k citations), Neurology (416 citations), Internal Medicine (82 citations), Modeling and Simulation (79 citations) and Critical Care and Intensive Care Medicine (76 citations). Hakam Abbass has collaborated with scholars based in United Kingdom, Australia and Vietnam. Frequent co-authors include Ross Jacob Hunter, Mark J. Earley, Pier David Lambiase, Shohreh Honarbakhsh, Simon Sporton, Anthony Chow, Gurpreet Singh Dhillon, Sophie Welch, Nikhil Ahluwalia and António Creta. Their work appears in journals such as The Lancet, JAMA, Journal of Cardiovascular Electrophysiology, Wellcome Open Research and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.